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Abstract
Palaeomicrobiology has detected the tuberculosis agent in animal and human skeletons that are thousands of years old. The German doctor
Robert Koch was the ﬁrst microbiologist to report in 1882 the successful isolation of the causative agent of tuberculosis, named 1 year later as
Mycobacterium tuberculosis. This immense discovery, however, was not made from scratch, but involved the combining of previous scientiﬁc
knowledge, chieﬂy the previous demonstration by the French doctor Jean-Antoine Villemin that tuberculosis was a transmissible disease, and
two innovations—a new staining procedure that allowed R. Koch to consistently observe the new organism in tuberculous lesions, and use of a
solidiﬁed, serum-based medium instead of broths for the culture. These innovations allowed R. Koch not only to isolate M. tuberculosis from
animal and patient specimens for the ﬁrst time, but also to reproduce the disease in experimentally inoculated guinea pigs. It is thanks to R. Koch
that one of the most lethal diseases in human history could be diagnosed, could be treated and cured after the discovery of streptomycin
65 years later, and could be efﬁciently prevented by isolation of cases. His microbiological innovations are now being renewed with molecular
and improved culture-based detection being the twenty-ﬁrst century weapons in the ﬁght against this disease, which remains a major killer.
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From Ancient Times to the Discovery of the
Tubercle Bacillus
Although mycobacteria were supposed to exist for about
150 million years [1], Mycobacterium tuberculosis is a young
species, aged about 150 000 years [2]. The disease itself,
tuberculosis, has been known for centuries [3]. Mummies from
the Egyptian pre-dynastic era and the Peruvian pre-Columbian
era show typical vertebral lesions [4,5]. The antiquity of
tuberculosis is attested by palaeomicrobiology, which provides
a demonstrative framework to assess the clinical descriptions
of doctors and patients through the centuries [6–8]. The ﬁrst
weak evidence for tuberculosis in humans relies on lesions
compatible with bone tuberculosis in a 500 000-year-old skull
in Turkey [9], the ﬁrst undisputed evidence of M. tuberculosis
was obtained by PCR sequencing and detection of mycobac-
terial lipids in bone lesions of a 17 000-year-old bison found in
Wyoming, USA [10,11]. Much work was then done to attest to
the presence of human tuberculosis in several burial sites in
Europe [7,12] and in Asia [13]. The oldest evidence for human
tuberculosis was found in a Neolithic infant and woman in a
9000-year-old settlement in the Eastern Mediterranean [13].
The vast majority of studies detecting M. tuberculosis DNA
sequences have used bone as the material on which to base the
diagnosis, whereas a few works used lung tissue [14,15] or
other soft tissues [16].
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The literature is full of tuberculosis descriptions. This
frequent disease was named as schachepheth in the Old
Testament [3], phthisis as described by Hippocrates in Greek
literature, cunsumptio in Latin reports from the Roman Cicero
and consumption in many occidental myths of the nineteenth
century (such as La Dame aux Camelias and La Traviata) and in
the deaths of Chopin and Chekov. Johann Lukas Sch€onlein
eventually uniﬁed the nosology and proposed the name
‘tuberculosis‘ in 1834 due to the presence of tubercles in all
forms of the disease.
Indeed, the discovery of M. tuberculosis by Robert Koch
(1843–1910) came into a framework of previous popular and
scientiﬁc knowledge regarding tuberculosis. Hippocrates con-
sidered tuberculosis to be hereditary. Galen (131–201) ﬁrst
suspected that it could be transmitted, then Girolamo
Francastoro (1483–1553) showed that some diseases could
be transmitted through ‘particles‘ by direct or indirect contact
between humans. Some people, such as the English physician
Benjamin Marten (1690–1752), already hypothesized in 1720
that consumptions could be caused by ‘wonderfully minute
living creatures‘, which could lead to the lesions that are
symptomatic of the disease, thereby expressing the theory of
‘contagious living ﬂuid’ [17]. He went on to state that ‘it may
be therefore very likely that by a habitual lying in the same bed
with a consumptive patient, constantly eating and drinking with
him, or by very frequently conversing so nearly as to draw in
part of the breath he emits from the lungs, a consumption may
be caught by a sound person … I imagine that slightly
conversing with consumptive patients is seldom or never
sufﬁcient to catch the disease.‘ Marten’s epidemiological insight
was prescient, but was not really helpful in the absence of
direct observation or experimental data. Although Leeuwen-
hoek had reported seeing bacteria in 1676, he had not believed
that his ‘little animals‘ caused disease. Koch’s discovery was
made within the framework of the theory of germs that was
progressively elaborated in Europe during the ﬁrst half of the
nineteenth century.
Tuberculosis: Dispute on the Unicity of a
Disease
Clinical signs, symptoms and lethality (50% of the cases)
attributed to tuberculosis were more precisely described
during the nineteenth century. Whether typical Pott spondy-
litis was related to lung consumption (Hammurabi 1950 BC)
and scrofula (described by Aristotle, 384–322 BC) was dis-
cussed for centuries. Finally, Sylvius de la Bo€e of Amsterdam
(1617–1655) then Rene Theophile Hyacinthe Laennec (1781–
1826), agreed that they were several clinical and anato-
mo-pathological forms of the same disease. Typical clinical
signs of tuberculosis had already been reported earlier by a
Roman physician (500 BC) with typical coughing associated
with fever during the night with sweats. The miliary tubercu-
losis, as described by Thomas Willis (1621–1675), seemed to
be more frequent at that time than it is now, probably because
it was the era before bacillus Calmette–Guerin (BCG)
vaccination.
A further step was made when human tuberculosis was
related to the animal disease, especially that observed in cattle.
Jacob Henle (1809–1885) observed the transmission from cat
to human and inoculated human specimens to rabbits. He
opened the ﬁeld to Robert Koch, who stained bacilli from
human lesions as well as those from animal lesions from cows,
pigs, hens, monkeys, rabbits and guinea pigs. It was acknowl-
edged that M. tuberculosis infection causes various forms of
diseases, depending on the affected organ and tissue. Pulmo-
nary tuberculosis was less prevalent than it is today because
the oral route and airborne transmission were probably
equally successful.
Jean-Antoine Villemin Demonstrated the
Transmissibility of the Disease
The transmission of ‘consumption‘ from a coughing patient to
a healthy person was just unbelievable for people living before
the nineteenth century because tuberculosis was considered
to be inherited or congenital or spontaneous. Decades were
needed to show that tuberculosis was transmitted from human
to human, from human to animal or from animal to human.
Interestingly, the ﬁrst sentence of the seminal paper by Koch
acknowledges previous work by Jean-Antoine Villemin (1827–
1892), a French army doctor, who ﬁrst demonstrated the
transmissibility of tuberculosis [18] (Fig. 1).
In fact, Jean-Antoine Villemin, successfully transmitted
tuberculosis from patient to rabbit, from cow to rabbit and
from rabbit to rabbit as early as 1865 [19,20]. These seminal
data were further conﬁrmed by John Sanderson and John
Simon, appointed by the British Government to investigate
that topic [21]. Tappeiner was the ﬁrst to describe a guinea pig
model with bacillus inhalation [21].
Robert Koch’s Discovery of the Tubercle
Bacilli
On 24 March 1882, the German doctor Robert Koch
communicated to the Berlin Society of Physiology that he
had discovered the microorganism responsible for the deadly
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pulmonary tuberculosis, named Tuberkelvirus in his seminal
publication made 2 weeks later [18] (Fig. 1). These ﬁrst
isolates of the aetiological agent are now displayed at the
Hunterian Museum at the Royal College of Surgeons of
England, London, UK [22]. The tuberculosis agent was named
as Mycobacterium tuberculosis in 1883 [23]. Further molecular
analysis of these very ﬁrst isolates conﬁrmed the identiﬁcation
of M. tuberculosis and indicated that Koch’s isolates belong to
the ‘modern‘ lineage of M. tuberculosis.
Staining tuberculosis bacteria was a ﬁrst, decisive innovation
made by R. Koch and his team. As stated by R. Koch himself,
the goal was to demonstrate the presence of ‘foreign parasitic
structures… indicative of the causal agent‘. However, R. Koch
stated that ‘the staining methods which have been so useful in
the demonstration of pathogenic micro-organisms have been
unsuccessful here‘ [18]. Indeed, R. Koch observed that the
alcohol-methylene blue staining developed by Karl Weigert in
1875 [24] did not easily stain in tuberculous lesions. Tubercle
bacilli were stained only after a long 24-hour contact with
Weigert’s blue and further contact with KOH, before being
counterstained by vesuvine, exactly as the leprosy bacillus [25].
R. Koch also noticed that heating the preparation at 40°C
greatly reduced the time required for methylene blue staining
to only 1 hour. Using this staining, R. Koch reported that the
animal tissue structures stained brown whereas tubercle
bacteria stained a beautiful blue, contrary to any other
bacteria, which stained brown [17]. R. Koch insisted that the
contrast between brown-coloured tissues and blue-coloured
tubercle bacteria rendered them easily detected by micros-
copy. Paul Ehrlich and then R. Koch, further modiﬁed the
staining protocol (notably by heating stained slides), and the
technique was ﬁnalized by Ziehl and Neelsen in 1885 [25].
Using this new staining method, R. Koch reported that the
tubercle bacteria are rod-shaped organisms appearing as bacilli
and looking very similar to the leprosy bacilli. He noticed that
bacilli appeared as grouped within the lesions, either intracel-
lularly or extracellularly.
At that point, R. Koch noticed that the repeated observa-
tion of tubercle bacilli was not proof for this organism being
the aetiological agent of tuberculosis. However, these micro-
scopic observations convinced him that the microbial hypoth-
esis of tuberculosis was right and paved the way to tentative
isolation of the bacilli in pure culture.
R. Koch then embarked on isolating the tuberculosis bacillus.
Development of solid culture media instead of the culture
broths used at that time was a second decisive innovation. In
fact, R. Koch had already published descriptions of such solid
media before he used them to isolate M. tuberculosis [26]. He
simply used solidiﬁed cow or sheep serum, with sterilization
being obtained by repeated, short courses of heating at 58°C, i.e.
a procedure previously reported by Tyndall. Final, prolonged
heating at 65°C then solidiﬁed themedium, which was poured in
FIG. 1. Front page of the seminal paper published in 1882 by Robert Koch, reporting the ﬁrst ever culture of Mycobacterium tuberculosis.
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slanted tubes so as to increase the surface available for
inoculation. This also permitted the tube to be kept for weeks
without contamination, although it contained the rich medium
necessary for M. tuberculosis growth. After inoculation, tubes
were incubated at 37–38°Cand growing colonieswere detected
by the naked eye. Initial experiments were made by inoculating
experimentally infected guinea pig lung tissues and colonies
were observed after 10–14 days. Further, a total of 15 pure
cultures were obtained from four experimentally infected
guinea pigs, four from bovine tuberculosis and seven from
patients. Interestingly, R. Koch noticed that detection of
growing colonies using 309 to 409 magniﬁcation allowed
detection of colonies by the end of the ﬁrst week [18].
This great discovery gave Robert Koch the Nobel Prize of
Medicine in 1905 ‘for his investigations and discoveries in
relation to tuberculosis‘ (Nobel Foundation website) and a
worldwide reputation that is still strong after more than
130 years.
Koch’s Postulates: to Demonstrate the
Cause of the Disease being an Infectious
Agent
R. Koch was not only able to isolate and then culture this new
microorganism from sputum, but also to demonstrate that the
disease was due to an external cause, an ‘infectious agent‘.
Three steps were necessary to achieve this demonstration.
First, the infectious agent was observed in lesions typical of the
disease but not in other lesions or in normal tissues. Second,
the infectious agent was cultured in vitro outside the infected
human or animal. Third, the infectious agent, after growing in
vitro, was reintroduced into a non-infected animal and led to
typical tuberculosis lesions. The disease was reproduced in vivo
with the same features by using specimens either from a
tuberculosis patient or an animal or the culture: pus, sputum
and lung tissues were inoculated to guinea pigs, rabbits and
cats; cultures were inoculated to guinea pigs. The same lesions
appeared in 2 weeks and death was observed in 8 weeks. All
inoculated animals showed disease but none of the non-inoc-
ulated animals showed disease. However, non-inoculated
guinea pigs became infected when living in the same room as
inoculated animals. This showed the airborne route of
transmission of the infectious agent.
From Discovery to Eradication
At the time when the bacillus was discovered, in early 1882,
one out of seven world inhabitants was dying from tubercu-
losis [18], which would be about one billion deaths per year in
2013 if nothing had happened since the Koch postulates.
The demonstration that (i) a bacterium, Mycobacterium
tuberculosis, was responsible for the tuberculosis disease, that
(ii) this bacterium was transmitted from human to human, and
that (iii) this disease can only be acquired through transmission
from a patient or animal with tuberculosis, helped in stopping
the spread of the disease. This was the beginning of a trend to
its eradication. Robert Philip launched in 1887 a large
programme of active prevention of tuberculosis transmission
in Edinburgh [27,28].
When the tuberculin, a protein that was also produced by
R. Koch, was extracted from large cultures of the bacillus by
Calmette, it was ﬁrst used as a therapy, ‘tuberculinisation‘,
which failed, and second for the diagnosis of tuberculosis with
the well-known tuberculin skin test. The description of the
intra-dermal reaction by Charles Mantoux led to an under-
standing of much of the immunology and physiopathology of
tuberculosis infection [29]. By reading his report to the Societe
de Biologie, one may consider that very little has changed from
1910 to 2013 considering the results of interferon-c release
assay testing [30].
The same Leon Charles Albert Calmette (1863–1933),
together with Camille Guerin (1872–1961), sub-cultured more
than 200 times, between 1908 and 1921, a peculiar strain
called Mycobacterium bovis, and showed that the resulting
bacterium had lost its virulence in the guinea pig model [31,32].
The era of vaccination was started. BCG immunization greatly
reduced the number of meningitis cases in infants and the
incidence of miliary forms, even in adults [33]. It is now known,
a hundred years later, that M. bovis BCG is a variant
harbouring more than 12 DNA deletions with regard to
M. tuberculosis [34].
Finally, the discovery of streptomycin in 1943 by Albert
Schatz, directed for this PhD thesis by Selman Waksman
(Nobel Prize 1952), ended the great period of discoveries
concerning tuberculosis [35,36]. Whether the genomic deci-
phering of the tubercle bacillus will help to eradicate tuber-
culosis in the world during the twenty-ﬁrst century is still a
hope.
R. Koch’s Lesson
R. Koch paved the way to culture-based diagnosis of tuber-
culosis. In fact, the results he obtained have not been
surpassed by further developments in culture media that
aimed to abandon serum in order to use more easily available
ingredients such as egg and further synthetic media. This may
have been a mistake because the time to detection routinely
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achieved is usually longer than the 1 week reported by R.
Koch. The chance observation that sheep-blood agar sup-
ported the growth of M. tuberculosis [37,38] led to a renewed
interest in media containing sheep blood [39,40] and recently,
a sheep serum-agar medium was reported for testing
M. tuberculosis antibiotic susceptibility [40]. We recommend
that the basic R. Koch medium is not forgotten. Strategies
coupling rapidly growing medium, early detection and rapid
identiﬁcation should be targeted by the mycobacteriologists of
the twenty-ﬁrst century [41,42]. The new weapon for ﬁghting
tuberculosis is currently molecular detection [43], and it brings
the hope of eradicating the disease in the near future.
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